Quantitative structure-activity relationship of spirosuccinimide type aldose reductase inhibitors diminishing sorbitol accumulation in vivo
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, Kwangseok | - |
dc.contributor.author | Won, Hoshik | - |
dc.contributor.author | Won, Youngdo | - |
dc.date.accessioned | 2021-06-23T21:40:25Z | - |
dc.date.available | 2021-06-23T21:40:25Z | - |
dc.date.issued | 2006-05 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.issn | 1464-3391 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/44893 | - |
dc.description.abstract | Racemate physicochemical descriptors are employed to probe the quantitative structure-activity relationship of spirosuccinimide type aldose reductase inhibitors and the in vivo inhibitory activity of sorbitol accumulation. The in vivo activity data include the percent inhibition and ED50 assay results on the literature. The derived QSAR equations show that the hydrophobic character of aldose reductase inhibitor is the major contributing factor to enhance in vivo activity. As the hydrophobicity of compounds is related to both the membrane permeability and the binding affinity to the aldose reductase, its contribution to the pharmacokinetic behavior is further scrutinized by evaluating pK(a) and the Caco-2 cell permeability. The high correlation between ED50 and the Caco-2 cell permeability of in vitro active compounds indicates that the membrane permeability is essential for in vivo efficacy. (c) 2005 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.title | Quantitative structure-activity relationship of spirosuccinimide type aldose reductase inhibitors diminishing sorbitol accumulation in vivo | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.bmc.2005.12.019 | - |
dc.identifier.scopusid | 2-s2.0-33644966974 | - |
dc.identifier.wosid | 000236591200022 | - |
dc.identifier.bibliographicCitation | Bioorganic and Medicinal Chemistry, v.14, no.9, pp 3090 - 3097 | - |
dc.citation.title | Bioorganic and Medicinal Chemistry | - |
dc.citation.volume | 14 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 3090 | - |
dc.citation.endPage | 3097 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | DESCRIPTORS | - |
dc.subject.keywordPlus | AS-3201 | - |
dc.subject.keywordAuthor | QSAR | - |
dc.subject.keywordAuthor | aldose reductase inhibitor | - |
dc.subject.keywordAuthor | sorbitol accumulation | - |
dc.subject.keywordAuthor | Caco-2 cell permeability | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0968089605012034?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.